ArticleBlood2022
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
Naja Nyffenegger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleBlood2022
Naja Nyffenegger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.